Product Program year 2024 Source: CMS Open Payments

Intercept Blood System for Cryoprecipitation

Device Device-Transfusion

PDI 18717953197013

Open in the dashboard

General payments

$370,691

140 payments

Research payments

$863,383

5 payments

Through program year 2024, $370,691 in general payments and $863,383 in research payments were reported against Intercept Blood System for Cryoprecipitation (Device-Transfusion).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2024 General $112,465 53
2024 Research $605,381 3
2023 General $153,667 49
2023 Research $258,003 2
2022 General $62,010 15
2021 General $42,550 23

Breakdown

Who paid General payments · program years 2021–2024
  1. Cerus Corporation $370,691 140 payments
Top recipients General payments · program year 2024
  1. Scott Lemaire Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TX $14,584 13% · 4 payments
  2. Majed Refaai Clinical Pathology · Rochester, NY $12,862 11% · 3 payments
  3. Lucy Kornblith Surgery · San Francisco, CA $12,273 11% · 4 payments
  4. Thorsten Haas Anesthesiology · Gainesville, FL $11,494 10% · 4 payments
  5. Melissa Cushing Clinical Pathology/Laboratory Medicine · New York, NY $8,600 8% · 4 payments

The top 5 of 17 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Anesthesiology $27,527 24% · 5 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $14,584 13% · 1 practitioner
  3. Clinical Pathology Pathology $12,862 11% · 1 practitioner
  4. Surgery $12,273 11% · 1 practitioner
  5. Anatomic Pathology & Clinical Pathology Pathology $8,827 8% · 3 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $23,805 21% · 4 recipients
  2. Texas $21,737 19% · 2 recipients
  3. New York $21,462 19% · 2 recipients
  4. Florida $13,124 12% · 2 recipients
  5. Missouri $9,833 9% · 2 recipients

The top 5 of 8 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

140 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record